Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 4Active not recruiting 4Recruiting 2Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2Sarcoma 1NET 1Genitourinary 1Gastrointestinal 1Endocrine 1CNS 1

Conditions

Ovarian Neoplasms 507Uterine Cervical Neoplasms 361Endometrial Neoplasms 304Breast Neoplasms 130Colorectal Neoplasms 112Neoplasms 98Fallopian Tube Neoplasms 90Carcinoma, Non-Small-Cell Lung 87Stomach Neoplasms 83Pancreatic Neoplasms 79Lung Neoplasms 72Melanoma 68Prostatic Neoplasms 67Carcinoma, Ovarian Epithelial 65Neoplasm Metastasis 63Triple Negative Breast Neoplasms 51Vulvar Neoplasms 50Squamous Cell Carcinoma of Head and Neck 49Head and Neck Neoplasms 45Esophageal Neoplasms 43Uterine Neoplasms 40Peritoneal Neoplasms 40Urinary Bladder Neoplasms 38Carcinoma, Hepatocellular 35Carcinoma, Renal Cell 34Uterine Cervical Dysplasia 31Sarcoma 31Papillomavirus Infections 31Colonic Neoplasms 31Recurrence 29

Interventions

liposomal doxorubicin 1dostarlimab 1Paclitaxel 1Gemcitabine 1Doxorubicin 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Adenocarcinoma, Clear Cell × Gynecologic × Clear all
NCT06023862 2026-05-06

DOVE

Yonsei University

Phase 2 Recruiting
198 enrolled
Gynecologic

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

NCT05460000 2026-02-12

N-Plus

North Eastern German Society of Gynaecological Oncology

Phase 2 Recruiting
640 enrolled
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Adenocarcinoma, Clear Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡